23 April 2024
Researchers from The University of Birmingham have created a new £12M research centre to improve clinical trials for rare diseases.
14 February 2024
Partnership agreement with Acticor Biotech sees first patient treated in the LIBERATE clinical study to evaluate glenzocimab efficacy in myocardial infarction.
02 February 2024
To mark four decades of funding, the Birmingham Cancer Research UK Clinical Trials Unit (CRCTU) held a special celebratory event in January.
09 January 2024
Phase 2 trial found adding Bevacizumab to different chemotherapy drugs led to more patients’ tumours shrinking, which has helped to change routine UK treatment.
19 December 2023
Professor Amos Burke has been appointed as the new Director of the Cancer Research UK Clinical Trials Unit, based at the University of Birmingham.
09 June 2023
University of Birmingham set for renewal of pioneering Cancer Research Clinical Trials Unit which delivers more than 100 national and international trials
12 May 2023
Patients with aggressive brain tumours may be able to take part in a new trial of a cannabinoid-based drug, coordinated by the University of Birmingham.
04 May 2023
Cancer Research UK Clinical Trials Unit-sponsored trial found new drug better for treating rare cancer for patients not responding to first line treatment
28 October 2022
A UK-based leading clinical trials unit involves patients and members of the public across all areas of its work and is keen to learn how they can do better.
14 October 2022
Renewed National Institute for Health and Care Research Birmingham Biomedical Research Centre continue funds for developments around inflammatory diseases